Prospective multicenter cohort for evaluation of changes in Immune profile and platelet function after start of TPO-receptor agonist in patients with chronic ITP

Prospective multicenter cohort for evaluation of changes in Immune profile and platelet function after start of TPO-receptor agonist in patients with chronic ITP - Changes in immune profiles and platelet function after start TPO-RA in ITP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55371

Enrollment

Registered

2019-02-27

Start date

2019-12-05

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune thrombocytopenia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 16 years and older - Previously confirmed diagnosis of primary ITP with current platelet counts of

Exclusion criteria

Exclusion criteria: - Documented history of persisting severe anemia (defined as hemoglobin

Design outcomes

Primary

Measure	Time frame
monitor B and T cell profiles and changes in platelet function and reactivity in adult patients with ITP who are treated with eltrombopag.	—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Outcome results